Elucidating the up-regulation mechanism of placental P-gp, seeking the specific targets for reducing the transplacental transfer rates of toxicants and their adverse effects on cardiac development, and subsequently forwarding CHD prevention front, might provide a brand-new insight for primary prevention of CHD in the profile of placenta. Here, PGP is linked to coronary artery disorder.